UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Astrana Health
ASTH
$1.86B
| $1.28M | ﹤0.01% |
43,389
+5,790
| +15% | +$186K |
|
1677
FormFactor
FORM
$8.79B
| $1.28M | ﹤0.01% |
57,698
-2,886
| -5% | -$67.3K |
|
1678
Douglas Dynamics
PLOW
$984M
| $1.28M | ﹤0.01% |
35,391
| – | – |
|
1679
Warby Parker
WRBY
$3.26B
| $1.28M | ﹤0.01% |
94,734
| – | – |
|
|
AVNS
1680
DELISTED
Avanos Medical
AVNS
| $1.28M | ﹤0.01% |
47,224
+5,953
| +14% | +$146K |
|
1681
Zillow
ZG
$7.66B
| $1.28M | ﹤0.01% |
40,929
-641
| -2% | -$21K |
|
1682
Heritage Financial
HFWA
$1.2B
| $1.28M | ﹤0.01% |
41,671
+6,633
| +19% | +$208K |
|
|
CIM
1683
Chimera Investment
CIM
$980M
| $1.28M | ﹤0.01% |
77,282
+16,630
| +27% | +$310K |
|
|
EHAB
1684
DELISTED
Enhabit
EHAB
| $1.27M | ﹤0.01% |
96,338
+11,978
| +14% | +$160K |
|
1685
Energy Recovery
ERII
$408M
| $1.27M | ﹤0.01% |
61,764
-1,783
| -3% | -$39K |
|
1686
Schrodinger
SDGR
$1.4B
| $1.27M | ﹤0.01% |
67,692
+8,030
| +13% | +$166K |
|
1687
Griffon
GFF
$4.75B
| $1.26M | ﹤0.01% |
35,215
+3,391
| +11% | +$113K |
|
1688
TriCo Bancshares
TCBK
$1.82B
| $1.26M | ﹤0.01% |
24,660
-1,120
| -4% | -$58.4K |
|
1689
Tidewater
TDW
$4.46B
| $1.26M | ﹤0.01% |
34,065
-4,902
| -13% | -$149K |
|
1690
Perimeter Solutions
PRM
$5.65B
| $1.25M | ﹤0.01% |
136,921
| – | – |
|
1691
InterDigital
IDCC
$8.99B
| $1.25M | ﹤0.01% |
25,287
+189
| +0.8% | +$9.22K |
|
|
TBI
1692
Trueblue
TBI
$323M
| $1.25M | ﹤0.01% |
63,828
+505
| +0.8% | +$10.2K |
|
1693
Clean Energy Fuels
CLNE
$355M
| $1.25M | ﹤0.01% |
240,236
+7,703
| +3% | +$47.3K |
|
1694
Phreesia
PHR
$769M
| $1.25M | ﹤0.01% |
38,576
-1,972
| -5% | -$53.5K |
|
1695
Sonic Automotive
SAH
$2.53B
| $1.25M | ﹤0.01% |
25,297
+1,107
| +5% | +$53K |
|
|
DVAX
1696
DELISTED
Dynavax Technologies
DVAX
| $1.24M | ﹤0.01% |
116,352
| – | – |
|
1697
Customers Bancorp
CUBI
$2.78B
| $1.24M | ﹤0.01% |
43,668
-7,660
| -15% | -$239K |
|
|
MODV
1698
DELISTED
ModivCare
MODV
| $1.24M | ﹤0.01% |
13,779
| – | – |
|
1699
Amphastar Pharmaceuticals
AMPH
$896M
| $1.24M | ﹤0.01% |
44,087
-2,336
| -5% | -$67.8K |
|
1700
Copa Holdings
CPA
$5.58B
| $1.23M | ﹤0.01% |
14,849
+772
| +5% | +$60.7K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.